EPS von NUGL, Inc. ist -0.01
Der Gewinn pro Aktie (EPS) ist der Anteil des Gewinns eines Unternehmens, der jeder im Umlauf befindlichen Stammaktie zugewiesen wird. Es wird der Verdünnung angepasst und über letzten zwölf Monate nachgerechnet.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America. The company was founded in 2018 and is based in Kingston, Jamaica.